Randomized Comparison of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery DisEase in Patients With DIABETES Mellitus.

Trial Profile

Randomized Comparison of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery DisEase in Patients With DIABETES Mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Aug 2014

At a glance

  • Drugs Zotarolimus (Primary) ; Sirolimus
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms ESSENCE-DM2
  • Most Recent Events

    • 28 Jul 2014 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 12 Sep 2013 Primary endpoint 'Late-loss' has been met according to results published in the American Journal of Cardiology.
    • 12 Sep 2013 Primary endpoint 'In-segment-restenosis' has been met according to results published in the American Journal of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top